US Broker Ratings

Bristol-Myers Squibb Company (BMY) Stock Analysis: Exploring the 16.81% Upside Potential for Investors

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector with a commanding market cap of $110.27 billion, continues to capture the attention of investors...

Danaher Corporation (DHR) Stock Analysis: Potential 36.79% Upside with Strong Buy Ratings

Investors looking for opportunities in the healthcare sector may find Danaher Corporation (NYSE: DHR) an intriguing prospect. With a market capitalization of $125.4 billion, Danaher stands..

Eli Lilly and Company (LLY) Stock Analysis: Navigating a 10.94% Upside Potential and Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturers’ space. With a staggering market cap..

Natera, Inc. (NTRA) Stock Analysis: Strong Buy Ratings and 12.38% Upside Potential

Individual investors with a keen eye on the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing prospect given its position in the diagnostics and..

Humana Inc. (HUM) Stock Analysis: Navigating a Competitive Healthcare Market with Strategic Growth

As one of the stalwarts in the healthcare plans industry, Humana Inc. (NYSE: HUM) continues to navigate the dynamic landscape of healthcare services with a market..

Waters Corporation (WAT) Stock Analysis: A Healthcare Powerhouse with 12.61% Upside Potential

Waters Corporation (NYSE: WAT), a leader in the healthcare sector’s diagnostics and research industry, has been a focal point for investors seeking robust growth opportunities. With..

Sanofi (SNY) Stock Analysis: Potential 31.90% Upside Amid Robust Dividend Yield

As the healthcare sector continues to attract investor interest, Sanofi (NASDAQ: SNY), a major player in the global pharmaceutical landscape, offers a compelling proposition with its..

Zoetis Inc. (ZTS) Stock Analysis: A Lucrative 58% Upside Awaits Investors

Zoetis Inc. (NYSE: ZTS) has carved a niche in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic animal health products. With..

Pfizer, Inc. (PFE) Investor Outlook: Unpacking the 15.78% Potential Upside and Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, is capturing the attention of investors with a compelling narrative of potential growth and income. As..

UnitedHealth Group (UNH) Stock Analysis: Strong Buy Ratings and Growth Potential in Healthcare Sector

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, operating a diversified business model through its four main segments: Optum Health,..

Stryker Corporation (SYK) Stock Analysis: A 25.67% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, presents a compelling investment opportunity, boasting both robust fundamentals and promising growth prospects. With a..

Vertex Pharmaceuticals (VRTX) Stock Analysis: 21.49% Potential Upside Piques Investor Interest

Vertex Pharmaceuticals Incorporated (VRTX), a leader in the biotechnology sector, continues to capture the attention of investors with its compelling growth prospects and robust financial health...

Medtronic plc (MDT) Stock Analysis: Exploring a 23.52% Upside Potential Amid Strong Buy Ratings

Medtronic plc (MDT), a global leader in the medical devices industry, offers an enticing prospect for investors seeking exposure to the healthcare sector. With a market..

Merck & Co., Inc. (MRK) Stock Analysis: Exploring a 13.94% Upside Potential for Investors

Merck & Co., Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, specifically within the drug manufacturers industry. With a robust market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Investors Eye Robust Growth Potential Amid Healthcare Dominance

Novo Nordisk A/S (NVO), a titan in the healthcare sector, continues to captivate investor interest with its formidable market presence and innovative contributions to the pharmaceutical..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 38.92% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a pioneer in the realm of minimally invasive surgical systems, has captured the attention of investors with its promising growth trajectory..

Novartis AG (NVS) Stock Analysis: Insights into Growth Potential and Market Position

Novartis AG (NVS), a global leader in the healthcare sector, continues to capture investor attention with its robust market presence and diverse pharmaceutical portfolio. Headquartered in..

Abbott Laboratories (ABT) Stock Analysis: Unveiling a 31.82% Potential Upside

Abbott Laboratories (NYSE: ABT) has long been a stalwart in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $153.99 billion,..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a 10.72% Potential Upside in the Healthcare Giant

As a titan in the healthcare sector, Johnson & Johnson (NYSE: JNJ) stands as a compelling figure in the investment landscape. With a robust market cap..

PPHE Hotel Group updates on strategic review and sale process developments

PPHE Hotel Group says its strategic review and formal sale process have progressed, with the Fattal proposal deemed not capable of delivery in its.....
Search

Funds

US Broker Ratings

PPHE Hotel Group updates on strategic review and sale process developments

PPHE Hotel Group says its strategic review and formal sale process have progressed, with the Fattal proposal deemed not capable of delivery in its.....
Search

Funds

US Broker Ratings

FTSE 100

Funds